ARDIAN PORTFOLIO COMPANY DEDALUS ACQUIRES DXC TECHNOLOGY’S HEALTHCARE SOFTWARE SOLUTIONS DIVISION
- Dedalus strengthens its leading position in the healthcare IT sector at European and global level by operating in 40 countries worldwide
- The deal is based on a strong complementarity in the sharing of the same methodologies and technologies for products development
- The acquisition will enable Dedalus to accelerate the digital transformation of the healthcare ecosystem through its scaled R&D capabilities
- Dedalus will employ over 5,500 people, with circa 2,000 solely in R&D, generating over 700 million euros in turnover
- More than 3 billion clinical documents are produced globally each year by professionals using Dedalus solutions
Florence, 21 July 2020 – Dedalus Group, a leading international healthcare software provider, announces that it has reached a binding agreement for the acquisition of the Healthcare Software Solutions division of US-based DXC Technology Company (NYSE: DXC). DXC Technology is one of the world’s largest IT services companies. Dedalus Group is 75% owned by Ardian.
The acquisition firmly establishes Dedalus as a leading global player in the hospital and diagnostic software solutions sector. It now has a presence in over 40 countries, holding leading positions in major European countries, including Germany, Italy, the UK, France and Spain.
With this acquisition, the business will generate future total turnover of around 700 million euros, creating the world’s largest R&D platform for this sector.
DXC Technology’s healthcare software division provides clinical healthcare software solutions for national and regional authorities, hospitals, diagnostic laboratories, general practitioners and outpatients. The business already holds a leading position across the UK/Ireland, Australia, New Zealand and Spain, and also a significant position across Northern Europe, Latin America, Asia, the Middle East and North America. It covers all aspects of clinical decision-making processes, improving the ability for collaboration of all healthcare stakeholders in the care of patients.
The deal capitalises on significant synergies between the two companies that will allow Dedalus to expand its existing business in major European markets, expand into new markets, and establish a long time skilled management team led by Dedalus CEO Andrea Fiumicelli and Giorgio Moretti, Chairman of the Company.
Andrea Fiumicelli, CEO of Dedalus Group, commented: ”This acquisition allows us to make significant strides in becoming a true global player. I am pleased to see the two companies sharing a common goal of catalysing the digital transformation of the global healthcare ecosystem. The healthcare industry is currently evolving significantly, and we look to tap into these changes and support the sector with our expertise and systems.”
Giorgio Moretti, Chairman of Dedalus Group, added: “The integration of DXC’s healthcare software solutions activities into Dedalus Group will accelerate our support and impact on more than 3 million healthcare professionals who operate thanks to our technologies”.
Yann Chareton, Managing Director Ardian Buyout, added: “Since our investment in 2016, we have supported Dedalus’ growth and development and are pleased to see the heights it has reached. Following the prior acquisition of the healthcare IT business of Agfa Group, this deal further enables Dedalus to make a decisive step in its consolidation strategy. We are extremely pleased to see such a significant goal achieved”.
Dedalus was assisted by UBS as financial advisor, CC as legal advisor, BCG for Strategic Due Diligence, KPMG for Accounting and fiscal Due Diligence and Techeconomy for Technical Due Diligence.
Founded in Florence in 1982 by the current Chairman Giorgio Moretti, Dedalus Group is the leading healthcare and diagnostic software provider in Europe and one of the largest in the world. The shareholding structure ensures stability and great financial capacity through the presence of Ardian, the largest private investment company in Europe and 4th in the world.
Starting in 2016, Dedalus has decided to accelerate its expansion strategy by targeting a growing demand for innovative and comprehensive ICT and Clinical transformation solutions. With the acquisition of Agfa Healthcare IT, Dedalus consolidates its leadership as pan-European player in healthcare software industry, with a leading position in Hospital IT (HCIS) and Diagnostic (DIS) in Germany, Italy and France, with a strong footprint in Austria, Switzerland, Spain, Belgium, China, Brazil and several locations in the Latin America, Middle East and Africa, reaching over 30 different countries. Today Dedalus employs over 3,500 highly skilled resources; it has the largest R&D software team in the sector in Europe with more than 1,100 people. Thanks to its undisputed cutting-edge portfolio of leading the new generation solutions, Dedalus covers the whole spectrum of needs for healthcare operators, supporting over 5000 hospitals and 5000 laboratories around the world.
DXC Technology Company (NYSE: DXC) helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. With decades of driving innovation, the world’s largest companies trust DXC to deploy our enterprise technology stack to deliver new levels of performance, competitiveness and customer experiences. Learn more about the DXC story and our focus on people, customers and operational execution at www.dxc.technology.
Ardian is a world-leading private investment house with assets of US$100bn managed or advised in Europe, the Americas and Asia. The company is majority-owned by its employees. It keeps entrepreneurship at its heart and focuses on delivering excellent investment performance to its global investor base.
Through its commitment to shared outcomes for all stakeholders, Ardian’s activities fuel individual, corporate and economic growth around the world.
Holding close its core values of excellence, loyalty and entrepreneurship, Ardian maintains a truly global network, with more than 670 employees working from fifteen offices across Europe (Frankfurt, Jersey, London, Luxembourg, Madrid, Milan, Paris and Zurich), the Americas (New York, San Francisco and Santiago) and Asia (Beijing, Singapore, Tokyo and Seoul). It manages funds on behalf of around 1.000 clients through five pillars of investment expertise: Fund of Funds, Direct Funds, Infrastructure, Real Estate and Private Debt.
For further information
ARDIAN / DEDALUS
Cristina Fossati, Luisella Murtas, Anna Pirtali
Tel: +39 02 8901 1300